annual CFF:
$608.85M+$604.66M(+14424.12%)Summary
- As of today (July 1, 2025), KYMR annual cash flow from financing activities is $608.85 million, with the most recent change of +$604.66 million (+14424.12%) on December 31, 2024.
- During the last 3 years, KYMR annual CFF has risen by +$358.57 million (+143.27%).
- KYMR annual CFF is now at all-time high.
Performance
KYMR Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$258.00K-$2.51M(-90.67%)Summary
- As of today (July 1, 2025), KYMR quarterly cash flow from financing activities is $258.00 thousand, with the most recent change of -$2.51 million (-90.67%) on March 31, 2025.
- Over the past year, KYMR quarterly CFF has dropped by -$353.50 million (-99.93%).
- KYMR quarterly CFF is now -99.93% below its all-time high of $353.76 million, reached on March 31, 2024.
Performance
KYMR quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$255.35M-$353.50M(-58.06%)Summary
- As of today (July 1, 2025), KYMR TTM cash flow from financing activities is $255.35 million, with the most recent change of -$353.50 million (-58.06%) on March 31, 2025.
- Over the past year, KYMR TTM CFF has dropped by -$101.44 million (-28.43%).
- KYMR TTM CFF is now -58.06% below its all-time high of $608.85 million, reached on December 31, 2024.
Performance
KYMR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KYMR Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -99.9% | -28.4% |
| 3 y3 years | +143.3% | +39.5% | +2.2% |
| 5 y5 years | +1644.0% | -99.7% | +175.4% |
KYMR Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -99.9% | +225.2% | -58.1% | +5991.4% |
| 5 y | 5-year | at high | >+9999.0% | -99.9% | +164.0% | -58.1% | +5991.4% |
| alltime | all time | at high | >+9999.0% | -99.9% | +164.0% | -58.1% | +5991.4% |
KYMR Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $258.00K(-90.7%) | $255.35M(-58.1%) |
| Dec 2024 | $608.85M(>+9900.0%) | $2.77M(-98.9%) | $608.85M(+0.1%) |
| Sep 2024 | - | $250.92M(>+9900.0%) | $608.02M(+70.4%) |
| Jun 2024 | - | $1.41M(-99.6%) | $356.90M(+0.0%) |
| Mar 2024 | - | $353.76M(>+9900.0%) | $356.79M(+8411.2%) |
| Dec 2023 | $4.19M(-97.3%) | $1.93M(-1038.8%) | $4.19M(-0.5%) |
| Sep 2023 | - | -$206.00K(-115.8%) | $4.21M(-97.3%) |
| Jun 2023 | - | $1.30M(+12.6%) | $154.91M(+0.6%) |
| Mar 2023 | - | $1.16M(-40.7%) | $153.97M(+0.6%) |
| Dec 2022 | $153.00M | $1.95M(-98.7%) | $153.00M(-0.1%) |
| Sep 2022 | - | $150.50M(>+9900.0%) | $153.10M(-38.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $364.00K(+96.8%) | $248.64M(-0.5%) |
| Mar 2022 | - | $185.00K(-91.0%) | $249.87M(-0.2%) |
| Dec 2021 | $250.28M(-13.5%) | $2.05M(-99.2%) | $250.28M(+0.7%) |
| Sep 2021 | - | $246.04M(>+9900.0%) | $248.50M(+25.0%) |
| Jun 2021 | - | $1.59M(+167.6%) | $198.73M(+1.0%) |
| Mar 2021 | - | $595.00K(+120.4%) | $196.74M(-32.0%) |
| Dec 2020 | $289.26M(+728.6%) | $270.00K(-99.9%) | $289.26M(+0.1%) |
| Sep 2020 | - | $196.28M(<-9900.0%) | $288.99M(+211.7%) |
| Jun 2020 | - | -$403.00K(-100.4%) | $92.72M(-0.4%) |
| Mar 2020 | - | $93.12M | $93.12M |
| Dec 2019 | $34.91M(-34.0%) | - | - |
| Dec 2018 | $52.93M | - | - |
FAQ
- What is Kymera Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Kymera Therapeutics?
- What is Kymera Therapeutics annual CFF year-on-year change?
- What is Kymera Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly CFF year-on-year change?
- What is Kymera Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kymera Therapeutics?
- What is Kymera Therapeutics TTM CFF year-on-year change?
What is Kymera Therapeutics annual cash flow from financing activities?
The current annual CFF of KYMR is $608.85M
What is the all time high annual CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash flow from financing activities is $608.85M
What is Kymera Therapeutics annual CFF year-on-year change?
Over the past year, KYMR annual cash flow from financing activities has changed by +$604.66M (+14424.12%)
What is Kymera Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of KYMR is $258.00K
What is the all time high quarterly CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash flow from financing activities is $353.76M
What is Kymera Therapeutics quarterly CFF year-on-year change?
Over the past year, KYMR quarterly cash flow from financing activities has changed by -$353.50M (-99.93%)
What is Kymera Therapeutics TTM cash flow from financing activities?
The current TTM CFF of KYMR is $255.35M
What is the all time high TTM CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM cash flow from financing activities is $608.85M
What is Kymera Therapeutics TTM CFF year-on-year change?
Over the past year, KYMR TTM cash flow from financing activities has changed by -$101.44M (-28.43%)